Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Sep 21, 2020

Axonics® Receives Health Canada Approval of Next Generation Implantable Neurostimulator

Sep 16, 2020

Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Finalist for Orange County

Sep 10, 2020

Axonics® Reports 2-Year Clinical Results from ARTISAN-SNM Pivotal Study

Sep 08, 2020

NICE Recommends Axonics® r-SNM System for Treating Overactive Bladder

Sep 03, 2020

Axonics® to Participate in Upcoming Investor Conferences

Sep 02, 2020

Axonics® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9

Aug 06, 2020

Axonics® Reports Second Quarter 2020 Results

Jul 27, 2020

Axonics® Announces 2-Year Topline Clinical Results from ARTISAN-SNM Pivotal Study

Jul 16, 2020

Axonics® to Report Second Quarter 2020 Results on August 6

Jul 13, 2020

Axonics® Reports Preliminary Second Quarter 2020 Revenue

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2021 Axonics Modulation Technologies, Inc. Axonics^® and Axonics Modulation Technologies^® are trademarks of Axonics Modulation Technologies, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap